- call +1-201-465-4211
- email sales@mrinsights.biz
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Scope of the Report:
Levonorgestrel is widely sales through Hospital, Drug Store and Online Sale. The most proportion of Levonorgestrel is sales through Drug Store, and the proportion is about 73%.
The worldwide market for Levonorgestrel is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Levonorgestrel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Market Segment by Applications, can be divided into
Hospital
Drug Store
Online Sale
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levonorgestrel product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Levonorgestrel, with price, sales, revenue and global market share of Levonorgestrel in 2017 and 2018.
Chapter 3, the Levonorgestrel competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levonorgestrel breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Levonorgestrel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Levonorgestrel sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Levonorgestrel Introduction
1.2 Market Analysis by Type
1.2.1 Levonorgestrel Table
1.2.2 Mixture Products
1.2.3 Hormone-releasing IUD
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Store
1.3.3 Online Sale
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Levonorgestrel Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Paladin Labs
2.2.1 Business Overview
2.2.2 Levonorgestrel Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Paladin Labs Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Foundation Consumer Healthcare
2.3.1 Business Overview
2.3.2 Levonorgestrel Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Foundation Consumer Healthcare Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Theramex (Teva)
2.4.1 Business Overview
2.4.2 Levonorgestrel Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Theramex (Teva) Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Levonorgestrel Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Apotex
2.6.1 Business Overview
2.6.2 Levonorgestrel Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Apotex Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 HRA Pharma
2.7.1 Business Overview
2.7.2 Levonorgestrel Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 HRA Pharma Levonorgestrel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Levonorgestrel Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Levonorgestrel Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Levonorgestrel Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Levonorgestrel Manufacturer Market Share in 2018
3.3.2 Top 6 Levonorgestrel Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Levonorgestrel Market Analysis by Regions
4.1 Global Levonorgestrel Sales, Revenue and Market Share by Regions
4.1.1 Global Levonorgestrel Sales and Market Share by Regions (2014-2019)
4.1.2 Global Levonorgestrel Revenue and Market Share by Regions (2014-2019)
4.2 North America Levonorgestrel Sales and Growth Rate (2014-2019)
4.3 Europe Levonorgestrel Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Levonorgestrel Sales and Growth Rate (2014-2019)
4.5 South America Levonorgestrel Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Levonorgestrel Sales and Growth Rate (2014-2019)
5 North America Levonorgestrel by Country
5.1 North America Levonorgestrel Sales, Revenue and Market Share by Country
5.1.1 North America Levonorgestrel Sales and Market Share by Country (2014-2019)
5.1.2 North America Levonorgestrel Revenue and Market Share by Country (2014-2019)
5.2 United States Levonorgestrel Sales and Growth Rate (2014-2019)
5.3 Canada Levonorgestrel Sales and Growth Rate (2014-2019)
5.4 Mexico Levonorgestrel Sales and Growth Rate (2014-2019)
6 Europe Levonorgestrel by Country
6.1 Europe Levonorgestrel Sales, Revenue and Market Share by Country
6.1.1 Europe Levonorgestrel Sales and Market Share by Country (2014-2019)
6.1.2 Europe Levonorgestrel Revenue and Market Share by Country (2014-2019)
6.2 Germany Levonorgestrel Sales and Growth Rate (2014-2019)
6.3 UK Levonorgestrel Sales and Growth Rate (2014-2019)
6.4 France Levonorgestrel Sales and Growth Rate (2014-2019)
6.5 Russia Levonorgestrel Sales and Growth Rate (2014-2019)
6.6 Italy Levonorgestrel Sales and Growth Rate (2014-2019)
7 Asia-Pacific Levonorgestrel by Country
7.1 Asia-Pacific Levonorgestrel Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Levonorgestrel Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Levonorgestrel Revenue and Market Share by Country (2014-2019)
7.2 China Levonorgestrel Sales and Growth Rate (2014-2019)
7.3 Japan Levonorgestrel Sales and Growth Rate (2014-2019)
7.4 Korea Levonorgestrel Sales and Growth Rate (2014-2019)
7.5 India Levonorgestrel Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Levonorgestrel Sales and Growth Rate (2014-2019)
8 South America Levonorgestrel by Country
8.1 South America Levonorgestrel Sales, Revenue and Market Share by Country
8.1.1 South America Levonorgestrel Sales and Market Share by Country (2014-2019)
8.1.2 South America Levonorgestrel Revenue and Market Share by Country (2014-2019)
8.2 Brazil Levonorgestrel Sales and Growth Rate (2014-2019)
8.3 Argentina Levonorgestrel Sales and Growth Rate (2014-2019)
8.4 Colombia Levonorgestrel Sales and Growth Rate (2014-2019)
9 Middle East and Africa Levonorgestrel by Countries
9.1 Middle East and Africa Levonorgestrel Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Levonorgestrel Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Levonorgestrel Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Levonorgestrel Sales and Growth Rate (2014-2019)
9.3 Turkey Levonorgestrel Sales and Growth Rate (2014-2019)
9.4 Egypt Levonorgestrel Sales and Growth Rate (2014-2019)
9.5 Nigeria Levonorgestrel Sales and Growth Rate (2014-2019)
9.6 South Africa Levonorgestrel Sales and Growth Rate (2014-2019)
10 Global Levonorgestrel Market Segment by Type
10.1 Global Levonorgestrel Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Levonorgestrel Sales and Market Share by Type (2014-2019)
10.1.2 Global Levonorgestrel Revenue and Market Share by Type (2014-2019)
10.2 Levonorgestrel Table Sales Growth and Price
10.2.1 Global Levonorgestrel Table Sales Growth (2014-2019)
10.2.2 Global Levonorgestrel Table Price (2014-2019)
10.3 Mixture Products Sales Growth and Price
10.3.1 Global Mixture Products Sales Growth (2014-2019)
10.3.2 Global Mixture Products Price (2014-2019)
10.4 Hormone-releasing IUD Sales Growth and Price
10.4.1 Global Hormone-releasing IUD Sales Growth (2014-2019)
10.4.2 Global Hormone-releasing IUD Price (2014-2019)
11 Global Levonorgestrel Market Segment by Application
11.1 Global Levonorgestrel Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Drug Store Sales Growth (2014-2019)
11.4 Online Sale Sales Growth (2014-2019)
12 Levonorgestrel Market Forecast (2019-2024)
12.1 Global Levonorgestrel Sales, Revenue and Growth Rate (2019-2024)
12.2 Levonorgestrel Market Forecast by Regions (2019-2024)
12.2.1 North America Levonorgestrel Market Forecast (2019-2024)
12.2.2 Europe Levonorgestrel Market Forecast (2019-2024)
12.2.3 Asia-Pacific Levonorgestrel Market Forecast (2019-2024)
12.2.4 South America Levonorgestrel Market Forecast (2019-2024)
12.2.5 Middle East and Africa Levonorgestrel Market Forecast (2019-2024)
12.3 Levonorgestrel Market Forecast by Type (2019-2024)
12.3.1 Global Levonorgestrel Sales Forecast by Type (2019-2024)
12.3.2 Global Levonorgestrel Market Share Forecast by Type (2019-2024)
12.4 Levonorgestrel Market Forecast by Application (2019-2024)
12.4.1 Global Levonorgestrel Sales Forecast by Application (2019-2024)
12.4.2 Global Levonorgestrel Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Levonorgestrel Picture
Table Product Specifications of Levonorgestrel
Figure Global Sales Market Share of Levonorgestrel by Types in 2018
Table Levonorg
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
